跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TIETARI TABLET 250MG - HSA Drug Approval Details
Approvals
/
HSA
/
TIETARI TABLET 250MG
Approved
THERAPEUTIC
TIETARI TABLET 250MG
TEVA OPERATIONS POLAND SP. Z O.O. (POLAND)
🇸🇬 Health Sciences Authority
Approval Date
Jan 4, 2016
Approval ID
a0166c040caf4570
Company
TEVA OPERATIONS POLAND SP. Z O.O. (POLAND)
Type
Therapeutic
Approval Details
Approval Id
a0166c040caf4570
Drug Name
TIETARI TABLET 250MG
Product Name
TIETARI TABLET 250MG
Approval Number
SIN14918P
Approval Date
2016-01-04
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
N03AX14
Atc Item Name
levetiracetam
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Levetiracetam
250.00 mg
LEVETIRACETAM
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 4, 2016
Approval ID
a0166c040caf4570
Type
Therapeutic
Back to HSA Approvals